Roche Enters $7.1 Billion Deal to Acquire Telavant
Swiss pharma giant Roche has entered an agreement to purchase Telavant Holdings, a Roivant company, owned by Roivant Sciences Ltd.
Read moreSwiss pharma giant Roche has entered an agreement to purchase Telavant Holdings, a Roivant company, owned by Roivant Sciences Ltd.
Read moreGSK plc has unveiled entering into a strategic collaboration with Chongqing Zhifei Biological Products, Ltd. (Zhifei), marking a pivotal move
Read moreElly Lilly announced plans to acquire POINT Biopharma, with the strategic move set to boost Lilly’s oncology capabilities with next-generation
Read moreOrano Med, a clinical-stage biotechnology company that develops the next generation of targeted therapies against cancer using the unique properties
Read morePeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kanagawa, Japan, led by President and CEO Patrick C. Reid, has
Read moreThe partnership with Samsung Bioepis Grants Novartis’ generic-drugs unit Sandoz exclusive commercialization rights for biosimilar SB17 Ustekinumab in Europe and
Read moreCustomized Bioconjugation Solutions for Pharma and IVD Industries Biosynth, a pivotal supplier of vital raw materials to the life science
Read moreBiosynth, a leading supplier of critical raw materials to the life science industry, is pleased to announce its recent acquisition
Read moreAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura) and PeptiDream Inc. (TSE: 4587, President and CEO: Patrick C.
Read moreWatlow®, a pioneering industrial thermal systems designer and manufacturer, is elevating its digital transformation of energy management and automation solutions
Read more